A. PAH Cases | |||||
Patient | Diagnosis | H-E Grade | Age (years) | Sex | Underlying conditions |
1a | APAH | II | 4Â months | Female | DORV and VSD |
2a | APAH | II | 5Â months | Female | Trisomy 18 and VSD |
3a | APAH | II | 6Â months | Female | DORV and VSD |
4a | APAH | II | 7Â months | Female | Trisomy 21, ASD, and VSD |
5 | IPAH | III | 13 | Female | Â |
6 | IPAH | IV | 16 | Female | Â |
7a | IPAH | IV | 17 | Female | Â |
8a | IPAH | IV | 19 | Female | Â |
9a | IPAH | III | 21 | Female | Â |
10 | IPAH | IV | 24 | Male | Â |
11 | APAH | VI | 29 | Male | Collagen disease |
12 | IPAH | IV | 39 | Female | Â |
13 | APAH | IV | 41 | Male | Malignant lymphoma |
14a | IPAH | III | 44 | Female | Â |
15a | IPAH | IV | 51 | Female | Â |
16a | APAH | III | 63 | Male | Collagen disease |
B. Age-matched controls | |||||
Patient | Age (years) | Sex | Underlying conditions | Â | Â |
17 | 3 | Female | Pneumonia | Â | Â |
18a | 4 | Male | Leukemia | Â | Â |
19a | 11 | Female | Biliary atresia | Â | Â |
20 | 14 | Female | Leukemia | Â | Â |
21a | 14 | Male | Leukemia | Â | Â |
22a | 15 | Male | Leukemia | Â | Â |
23a | 16 | Male | Hypertrophic cardiomyopathy | Â | Â |
24 | 17 | Male | Idiopathic myocarditis | Â | Â |
25a | 18 | Male | Ewing sarcoma | Â | Â |
26a | 22 | Female | Suicide | Â | Â |
27a | 23 | Female | Cerebral hemorrhage | Â | Â |
28a | 29 | Male | Chronic hepatitis | Â | Â |
29 | 42 | Male | Anterior mediastinal tumor | Â | Â |
30 | 43 | Female | Breast cancer | Â | Â |
31a | 47 | Female | Gastric cancer | Â | Â |
32a | 56 | Female | Subacute hepatitis | Â | Â |
C. Summary | |||||
 | No. | Median age | Males:females |  |  |
PAH cases | 16 | 20 y (4Â m - 63 y) | 4:12 | Â | Â |
IPAH | 9 | 21 y (13 y - 51 y) | 1:8 | Â | Â |
APAH | 7 | 7Â m (4Â m - 63 y) | 3:4 | Â | Â |
Age-matched controls | 16 | 18 y (3 y - 56 y) | 8:8 | Â | Â |